Pharming (NASDAQ:PHAR) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.03) by 340 percent. This is a 400 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $93.20 million which beat the analyst consensus estimate of $82.63 million by 12.79 percent. This is a 25.78 percent increase over sales of $74.10 million the same period last year.